Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
Clinical trial NCT05415137 · COMPLETED
Trial details
- NCT number
- NCT05415137
- Sponsor
- aTyr Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-15
- Primary completion
- 2025-06-25
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.